Form 8-K - Current report:
SEC Accession No. 0001193125-26-059551
Filing Date
2026-02-19
Accepted
2026-02-19 16:38:20
Documents
14
Period of Report
2026-02-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d25779d8k.htm   iXBRL 8-K 24423
2 EX-99.1 d25779dex991.htm EX-99.1 5413
6 GRAPHIC g25779dsp4a.jpg GRAPHIC 15207
  Complete submission text file 0001193125-26-059551.txt   163521

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cort-20260219.xsd EX-101.SCH 2849
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cort-20260219_lab.xml EX-101.LAB 17234
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cort-20260219_pre.xml EX-101.PRE 10811
17 EXTRACTED XBRL INSTANCE DOCUMENT d25779d8k_htm.xml XML 3539
Mailing Address 101 REDWOOD SHORES PARKWAY REDWOOD CITY CA 94065
Business Address 101 REDWOOD SHORES PARKWAY REDWOOD CITY CA 94065 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

EIN.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50679 | Film No.: 26655094
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)